Connection

L JEFFREY MEDEIROS to Leukemia, Erythroblastic, Acute

This is a "connection" page, showing publications L JEFFREY MEDEIROS has written about Leukemia, Erythroblastic, Acute.
  1. Acute erythroid leukemia. Arch Pathol Lab Med. 2010 Sep; 134(9):1261-70.
    View in: PubMed
    Score: 0.360
  2. Differential characteristics of TP53 alterations in pure erythroid leukemia arising after exposure to cytotoxic therapy. Leuk Res. 2022 07; 118:106860.
    View in: PubMed
    Score: 0.203
  3. Response to Dr. Bain's comment on our review article: Pure Erythroid Leukemia. Am J Hematol. 2017 10; 92(10):E622.
    View in: PubMed
    Score: 0.146
  4. Pure erythroid leukemia. Am J Hematol. 2017 03; 92(3):292-296.
    View in: PubMed
    Score: 0.140
  5. Myelodysplastic syndromes following therapy with hypomethylating agents (HMAs): development of acute erythroleukemia may not influence assessment of treatment response. Leuk Lymphoma. 2016; 57(4):812-9.
    View in: PubMed
    Score: 0.132
  6. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification. Mod Pathol. 2011 Mar; 24(3):375-83.
    View in: PubMed
    Score: 0.091
  7. Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease. Mod Pathol. 2010 Aug; 23(8):1113-26.
    View in: PubMed
    Score: 0.088
  8. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification. Blood. 2010 Mar 11; 115(10):1985-92.
    View in: PubMed
    Score: 0.086
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.